# To Assess the Safety and Efficacy of the Atrial Shunt Implant System in the Treatment of Patients With Chronic Left Heart Failure

> **NCT05486000** · NA · RECRUITING · sponsor: **Morningside (Nantong) Medical Co.,Ltd** · enrollment: 120 (estimated)

## Conditions studied

- Left Heart Failure

## Interventions

- **DEVICE:** Atrial shunt implant system

## Key facts

- **NCT ID:** NCT05486000
- **Lead sponsor:** Morningside (Nantong) Medical Co.,Ltd
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2022-08-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05486000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05486000, "To Assess the Safety and Efficacy of the Atrial Shunt Implant System in the Treatment of Patients With Chronic Left Heart Failure". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05486000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*